Data as of Dec 19
| +0.11 / +0.30%|
The 30 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 35.69, with a high estimate of 47.14 and a low estimate of 21.32. The median estimate represents a -3.51% decrease from the last price of 36.99.
The current consensus among 33 polled investment analysts is to Hold stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.